Pharmacokinetic, Pharmacodynamic, and Safety Profile of a Novel Anti-CD28 Domain Antibody Antagonist in Healthy Subjects
2016 · The Journal of Clinical Pharmacology · 43 citations
https://doi.org/10.1002/jcph.791
R
Rong Shi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
388
Citations
11
h-index
12
i10-index
Rong Shi is an academic researcher from Shanghai University. The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & Lymphoma Diagnosis and Treatment & HER2/EGFR in Cancer Research. The author has an h-index of 11, co-authored 26 publications.
Papers by this author
worksApplication of a Two-Analyte Integrated Population Pharmacokinetic Model to Evaluate the Impact of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Polatuzumab Vedotin in Patients with Non-Hodgkin Lymphoma
2020 · Pharmaceutical Research · 15 citations
https://doi.org/10.1007/s11095-020-02933-6
Correlations between plasma markers and brain Aβ deposition across the AD continuum: Evidence from SILCODE
2024 · Alzheimer s & Dementia · 12 citations
https://doi.org/10.1002/alz.14084
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat